Noticias

Noticias

  • Título: Covidien Acquires Reverse Medical Corporation
  • Fecha: 22-08-2014

  • DUBLIN,Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse MedicalCorporation, a privately held medical devicecompany focused on expanding the management of vascular disease. Financial terms of the transaction were not disclosed.

    “Covidienis focused on technologies that deliver improved patient care throughclinically relevant and economically valuable solutions,” said Brett Wall,president, Neurovascular, Covidien. “The acquisition of Reverse Medical iscomplementary to our existing portfolio and will allow us to leverage existingvascular technologies to compete in the worldwide vascular embolization market,which is growing at a double digit rate.”

    Covidien willreport the Reverse Medical business as part of its Neurovascular product linein the Medical Devices segment. Annualized dilution is not expected to bematerial.

    ReverseMedical is currently commercializing its vascular embolization plugs, MVP®Micro Vascular Plug System and UNO™ Neurovascular Embolization System. MVP andUNO are self-expanding vessel occlusion devices, which close blood vessels forvascular embolization. A number of clinical applications require occlusion ofthe vasculature to rapidly, effectively and safely provide blood flowcessation.

    OtherReverse Medical products include ReVerse® Microcatheter fordevice delivery and Barrel™ Vascular Reconstruction Device (VRD), aself-expandable bifurcation aneurysm bridging device. All the devices havereceived CE Mark approval and are commercially available inEurope.Additionally, MVP-3 and MVP-5 are 510(k) cleared in the U.S.



  • Fuente: endovascular.es